Pacific Biosciences of California, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PACB | TXG | LAB | 2170.HK | QSI | CTKB | |
|---|---|---|---|---|---|---|
| Market cap | 792.62M | 8.80B | 243.14M | 372.96M | 282.36M | 764.30M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -6.1 | 880.7 | -61.6 | -5.3 | -3.7 | 84.0 |
| Price/book | 141.7 | 10.7 | 0.4 | 0.4 | 1.6 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +27.08% | +383.99% | −46.49% | −43.28% | −27.78% | +48.63% |
| Today | +4.51% | +3.42% | +0.85% | +1.11% | −0.77% | −1.34% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All PACB news ›PacBio (PACB) reports Q3: everything you need to know ahead of earnings
Genomics company Pacific Biosciences of California PACB will be announcing earnings results this Wednesday after market hours. Here’s what you need to know. PacBio missed analysts’ revenue expectations last quarter, reporting revenues of…
PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales Expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the market’s revenue expectations in Q1 CY2026, with sales flat year on year at $37.18 million. Its non-GAAP loss of $0.12 per share was 8.7% above analysts’…
PacBio to Participate in Upcoming Investor Conferences
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ... PacBio to Participate in Upcoming Investor…
PacBio announces multi-year strategic collaboration with Verily Health
PacBio (PACB) and Verily Health announced a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health’s governed... PacBio announces multi-year strategic collaboration with Verily Health PacBio (PACB) and…
PacBio price target raised to $2.50 from $1.50 at Stephens
Stephens analyst Mason Carrico raised the firm’s price target on PacBio (PACB) to $2.50 from $1.50 and keeps an Overweight rating on the shares ... PacBio price target raised to $2.50 from $1.50 at Stephens Stephens analyst Mason Carrico…
Pacific Biosciences of California (PACB) Set to Release Quarterly Earnings on Tuesday
Posted by Kim Johansen on Oct 27th, 2026 Pacific Biosciences of California stock opened at $2.25 on Tuesday. The stock has a market capitalization of $699.37 million, a price-to-earnings ratio of -5.23 and a beta of 2.19. Pacific…
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7.3% – Time to Buy?
Posted by Sarita Garza on Oct 26th, 2026 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) rose 7.3% during trading on Monday. The stock traded as high as $2.24 and last traded at $2.2650. 2,589,406 shares…
More from 1 other outlet
Pacific Biosciences of California, Inc. Announces CEO Changes, Effective August 5, 2026
Pacific Biosciences of California, Inc. announced that its Board of Directors has appointed Mark Van Oene, age 54, as Chief Executive Officer, effective August 5, 2026. Mr. Van Oene, who has served as... Pacific Biosciences of California,…
Pacific Biosciences of California, Inc. Announces Resignation of Christopher M. Smith from Director, Effective July 8, 2026
Pacific Biosciences of California, Inc. announced that Christopher M. Smith, a member of the board of directors, resigned from the board, effective July 8, 2026. The company is not aware of any... Published on 07/09/2026 at 05:35 pm EDT…
Pacific Biosciences of California, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Pacific Biosciences of California, Inc. with the company of your choice via a Relative Strength chart. Real-time PACB price, Nasdaq stock exchange Relative Strength Chart Pacific Biosciences of California, Inc. Advanced Medical…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com7
- markets.businessinsider.com3
- themarketsdaily.com3
- timothysykes.com3
- stockstotrade.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.